GAITHERSBURG, Md., May 15 /PRNewswire/ -- MedImmune today announced that researchers will present eight abstracts from its respiratory disease program at the Annual Meeting of the American Thoracic Society, from May 18 to 20, 2008 in Toronto, Canada. Presentations are designed to showcase MedImmune's biologics capabilities.
"MedImmune is committed to finding innovative solutions that may one
day help patients struggling with respiratory diseases," said Tony Coyle,
vice president, head, autoimmunity inflammation and respiratory disease
research. "We are pleased to present a plethora of promising data that
could potentially address diseases such as asthma and chronic obstructive
MedImmune research scheduled to be presented includes:
-- Regulation of Lung Inflammation in Animal Models (Poster Session:
IL-33, the Ligand for T1/ST2, Induces Airway Hyperresponsiveness Via a
Mast Cell but Not T Cell Dependent Mechanism, publication page A63)
- Sunday, May 18 from 8:15 a.m.- 4:15 p.m., Metro Toronto Convention
Centre, Area E.
-- Viral Infection and Wheezing (Poster Session: Evidence for T-Lymphocyte
Independent Antibody Responses in Primary RSV Infection, publication
page A190)-Sunday, May 18 from 8:15 a.m. - 4:15 p.m., Metro Toronto
Convention Centre, Area A.
-- Chitins: Flying High (Symposium: Hyperresponsiveness and Inflammation
in a Murine Model of Asthma, publication page A501)- Monday, May 19 at
2:45 p.m., Ontario, Fairmont Royal York Hotel.
-- New Insights and Developing Controversies in Clinical Asthma (Poster
Session: Safety Profile, Pharmacokinetics and Biologic Activity of a
Single IV Dose of the Anti IL-5 Receptor Alpha Antibody MEDI-563 in
Patients with Mild Asthma, publication page A569)-Tuesday, May 20 from
8:15 a.m.- 11:00 a.m., Metro Toronto Convention Centre, Room 20
Copyright©2008 PR Newswire.
All rights reserved